Dimension Therapeutics IPO Research Information

Dimension Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Dimension Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Dimension Therapeutics	DMTX - NASDAQ	$14.00-$16.00	$13.00	$12.60	5.5 million	10/22/2015
Underwriter(s): Goldman Sachs & Co., Citigroup, Wells Fargo Securities
Co-Manager(s): Canaccord Genuity, Cantor Fitzgerald & Co.
Industry: Health Care
Filing(s): Filed 2015-09-14 Terms Added 2015-10-13

Dimension Therapeutics Quote & Chart - Click for current quote - DMTX

About Dimension Therapeutics (adapted from Dimension Therapeutics prospectus):
They are a leading gene therapy platform company focused on discovering and developing new therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "DMTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.